Loading…

Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice

•Osteoclast differentiation in mice with global deletion of Cyp27b1 (Cyp27b1 KO) was studied.•Cyp27b1 KO splenocytes gave rise to fewer osteoclasts in response to recombinant RANKL/M-CSF.•Cyp27b1 KO derived osteoclasts had enhanced resorptive capacity. The association between increased serum 25-hydr...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of steroid biochemistry and molecular biology 2016-11, Vol.164, p.353-360
Main Authors: Reinke, Daniel C., Kogawa, Masakazu, Barratt, Kate R., Morris, Howard A., Anderson, Paul H., Atkins, Gerald J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c387t-56a3bcb3a7b51f3266aaf53174962853cfd4ba9aa775a27f09bc1208acad01d63
cites cdi_FETCH-LOGICAL-c387t-56a3bcb3a7b51f3266aaf53174962853cfd4ba9aa775a27f09bc1208acad01d63
container_end_page 360
container_issue
container_start_page 353
container_title The Journal of steroid biochemistry and molecular biology
container_volume 164
creator Reinke, Daniel C.
Kogawa, Masakazu
Barratt, Kate R.
Morris, Howard A.
Anderson, Paul H.
Atkins, Gerald J.
description •Osteoclast differentiation in mice with global deletion of Cyp27b1 (Cyp27b1 KO) was studied.•Cyp27b1 KO splenocytes gave rise to fewer osteoclasts in response to recombinant RANKL/M-CSF.•Cyp27b1 KO derived osteoclasts had enhanced resorptive capacity. The association between increased serum 25-hydroxyvitamin D (25D) and reduced osteoclastic bone resorption is well known. Previously, we have demonstrated that mechanism by which this occurs, may include the conversion of 25D to 1,25-dihydroxyvitamin D (1,25D) by osteoclasts, catalysed by the CYP27B1 enzyme. Local 1,25D synthesis in osteoclasts was shown to regulate osteoclastogenesis and moderating resorptive activity. Thus, we hypothesised that osteoclasts differentiated from mice with global deletion of the Cyp27b1 gene (Cyp27b1 KO) would display enhanced resorptive capacity due to the lack of an ameliorating effect of 1,25D. Splenocytes isolated from Cyp27b1 KO mice or their wild-type (WT) littermates between 6 and 8 weeks of age were cultured under osteoclast-forming conditions for up to 14 days. Osteoclast formation was measured by staining for the osteoclast marker tartrate resistant acid phosphatase (TRAP). Bone resorption activity was measured by plating the cells on a bone-like substrate. In Cyp27b1 KO cultures, osteoclastogenesis was reduced, as indicated by fewer TRAP-positive multinucleated cells at all time points measured (p
doi_str_mv 10.1016/j.jsbmb.2015.11.015
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1826643558</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960076015301424</els_id><sourcerecordid>1826643558</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-56a3bcb3a7b51f3266aaf53174962853cfd4ba9aa775a27f09bc1208acad01d63</originalsourceid><addsrcrecordid>eNp9kE1P3DAURS3UCgbaX4CELHXTTVK_eGIniy6qEV8SUjdlwcqynRfkkMSD7SDNv6-HgS66YHUXPu_66hByDqwEBuLHUA7RTKasGNQlQJnjiKygkW0BVcU-kRVrBSuYFOyEnMY4MMY4B3lMTioheCu4XJGHyxfX4WyR9j5QPSYM2FEfE3o76pj8I84YXaRupnE74uztLiG1y5iWgJH2wU90s9tW0gB9yq9Pfkl0cha_kM-9HiN-fcszcn91-WdzU9z9vr7d_LorLG9kKmqhubGGa2lq6HlepnVf55nrVlRNzW3frY1utZay1pXsWWssVKzRVncMOsHPyPdD7zb45wVjUpOLFsdRz-iXqKDJnWte101Gv_2HDn4Jc16noJWNEFkbyxQ_UDb4GAP2ahvcpMNOAVN782pQr-bV3rwCUDny1cVb92Im7P7dvKvOwM8DgFnGi8OgonV7850LaJPqvPvwg7_gsJWP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1978662200</pqid></control><display><type>article</type><title>Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice</title><source>Elsevier</source><creator>Reinke, Daniel C. ; Kogawa, Masakazu ; Barratt, Kate R. ; Morris, Howard A. ; Anderson, Paul H. ; Atkins, Gerald J.</creator><creatorcontrib>Reinke, Daniel C. ; Kogawa, Masakazu ; Barratt, Kate R. ; Morris, Howard A. ; Anderson, Paul H. ; Atkins, Gerald J.</creatorcontrib><description>•Osteoclast differentiation in mice with global deletion of Cyp27b1 (Cyp27b1 KO) was studied.•Cyp27b1 KO splenocytes gave rise to fewer osteoclasts in response to recombinant RANKL/M-CSF.•Cyp27b1 KO derived osteoclasts had enhanced resorptive capacity. The association between increased serum 25-hydroxyvitamin D (25D) and reduced osteoclastic bone resorption is well known. Previously, we have demonstrated that mechanism by which this occurs, may include the conversion of 25D to 1,25-dihydroxyvitamin D (1,25D) by osteoclasts, catalysed by the CYP27B1 enzyme. Local 1,25D synthesis in osteoclasts was shown to regulate osteoclastogenesis and moderating resorptive activity. Thus, we hypothesised that osteoclasts differentiated from mice with global deletion of the Cyp27b1 gene (Cyp27b1 KO) would display enhanced resorptive capacity due to the lack of an ameliorating effect of 1,25D. Splenocytes isolated from Cyp27b1 KO mice or their wild-type (WT) littermates between 6 and 8 weeks of age were cultured under osteoclast-forming conditions for up to 14 days. Osteoclast formation was measured by staining for the osteoclast marker tartrate resistant acid phosphatase (TRAP). Bone resorption activity was measured by plating the cells on a bone-like substrate. In Cyp27b1 KO cultures, osteoclastogenesis was reduced, as indicated by fewer TRAP-positive multinucleated cells at all time points measured (p&lt;0.05) when compared to wild-type (WT) levels. However, Cyp27b1 KO osteoclasts demonstrated greater resorption on a per cell basis than their WT counterparts (p&lt;0.03). In addition, the ratio of expression of the pro-apoptotic gene Bax to the pro-survival gene Bcl-2 was decreased in Cyp27b1 KO cultures, implying that these smaller osteoclasts survive longer than WT osteoclasts. Our data indicate abnormal osteoclastogenesis due to the absence of CYP27B1 expression, consistent with the notion that endogenous metabolism of 25D optimises osteoclastogenesis and ameliorates the resulting activity of mature osteoclasts.</description><identifier>ISSN: 0960-0760</identifier><identifier>EISSN: 1879-1220</identifier><identifier>DOI: 10.1016/j.jsbmb.2015.11.015</identifier><identifier>PMID: 26639637</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>25-Hydroxyvitamin D ; 25-Hydroxyvitamin D3 1-alpha-Hydroxylase - deficiency ; 25-Hydroxyvitamin D3 1-alpha-Hydroxylase - genetics ; Acid phosphatase (tartrate-resistant) ; Animals ; Apoptosis ; Bcl-2 protein ; bcl-2-Associated X Protein - genetics ; bcl-2-Associated X Protein - metabolism ; Bone resorption ; Bone Resorption - genetics ; Bone Resorption - metabolism ; Bone Resorption - pathology ; Calcitriol - metabolism ; Cell cycle ; Cell Differentiation ; Clonal deletion ; CYP27B1 ; Gene deletion ; Gene Expression Regulation ; Metabolism ; Mice ; Mice, Knockout ; Osteoclast ; Osteoclastogenesis ; Osteoclasts ; Osteoclasts - metabolism ; Osteoclasts - pathology ; Osteogenesis - genetics ; Phosphatase ; Primary Cell Culture ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Spleen - cytology ; Spleen - metabolism ; Splenocytes ; Tartrate-Resistant Acid Phosphatase - genetics ; Tartrate-Resistant Acid Phosphatase - metabolism ; Vitamin D ; Vitamin D - analogs &amp; derivatives ; Vitamin D - metabolism</subject><ispartof>The Journal of steroid biochemistry and molecular biology, 2016-11, Vol.164, p.353-360</ispartof><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier BV Nov 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-56a3bcb3a7b51f3266aaf53174962853cfd4ba9aa775a27f09bc1208acad01d63</citedby><cites>FETCH-LOGICAL-c387t-56a3bcb3a7b51f3266aaf53174962853cfd4ba9aa775a27f09bc1208acad01d63</cites><orcidid>0000-0002-2745-3750</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26639637$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reinke, Daniel C.</creatorcontrib><creatorcontrib>Kogawa, Masakazu</creatorcontrib><creatorcontrib>Barratt, Kate R.</creatorcontrib><creatorcontrib>Morris, Howard A.</creatorcontrib><creatorcontrib>Anderson, Paul H.</creatorcontrib><creatorcontrib>Atkins, Gerald J.</creatorcontrib><title>Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice</title><title>The Journal of steroid biochemistry and molecular biology</title><addtitle>J Steroid Biochem Mol Biol</addtitle><description>•Osteoclast differentiation in mice with global deletion of Cyp27b1 (Cyp27b1 KO) was studied.•Cyp27b1 KO splenocytes gave rise to fewer osteoclasts in response to recombinant RANKL/M-CSF.•Cyp27b1 KO derived osteoclasts had enhanced resorptive capacity. The association between increased serum 25-hydroxyvitamin D (25D) and reduced osteoclastic bone resorption is well known. Previously, we have demonstrated that mechanism by which this occurs, may include the conversion of 25D to 1,25-dihydroxyvitamin D (1,25D) by osteoclasts, catalysed by the CYP27B1 enzyme. Local 1,25D synthesis in osteoclasts was shown to regulate osteoclastogenesis and moderating resorptive activity. Thus, we hypothesised that osteoclasts differentiated from mice with global deletion of the Cyp27b1 gene (Cyp27b1 KO) would display enhanced resorptive capacity due to the lack of an ameliorating effect of 1,25D. Splenocytes isolated from Cyp27b1 KO mice or their wild-type (WT) littermates between 6 and 8 weeks of age were cultured under osteoclast-forming conditions for up to 14 days. Osteoclast formation was measured by staining for the osteoclast marker tartrate resistant acid phosphatase (TRAP). Bone resorption activity was measured by plating the cells on a bone-like substrate. In Cyp27b1 KO cultures, osteoclastogenesis was reduced, as indicated by fewer TRAP-positive multinucleated cells at all time points measured (p&lt;0.05) when compared to wild-type (WT) levels. However, Cyp27b1 KO osteoclasts demonstrated greater resorption on a per cell basis than their WT counterparts (p&lt;0.03). In addition, the ratio of expression of the pro-apoptotic gene Bax to the pro-survival gene Bcl-2 was decreased in Cyp27b1 KO cultures, implying that these smaller osteoclasts survive longer than WT osteoclasts. Our data indicate abnormal osteoclastogenesis due to the absence of CYP27B1 expression, consistent with the notion that endogenous metabolism of 25D optimises osteoclastogenesis and ameliorates the resulting activity of mature osteoclasts.</description><subject>25-Hydroxyvitamin D</subject><subject>25-Hydroxyvitamin D3 1-alpha-Hydroxylase - deficiency</subject><subject>25-Hydroxyvitamin D3 1-alpha-Hydroxylase - genetics</subject><subject>Acid phosphatase (tartrate-resistant)</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Bcl-2 protein</subject><subject>bcl-2-Associated X Protein - genetics</subject><subject>bcl-2-Associated X Protein - metabolism</subject><subject>Bone resorption</subject><subject>Bone Resorption - genetics</subject><subject>Bone Resorption - metabolism</subject><subject>Bone Resorption - pathology</subject><subject>Calcitriol - metabolism</subject><subject>Cell cycle</subject><subject>Cell Differentiation</subject><subject>Clonal deletion</subject><subject>CYP27B1</subject><subject>Gene deletion</subject><subject>Gene Expression Regulation</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Osteoclast</subject><subject>Osteoclastogenesis</subject><subject>Osteoclasts</subject><subject>Osteoclasts - metabolism</subject><subject>Osteoclasts - pathology</subject><subject>Osteogenesis - genetics</subject><subject>Phosphatase</subject><subject>Primary Cell Culture</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Spleen - cytology</subject><subject>Spleen - metabolism</subject><subject>Splenocytes</subject><subject>Tartrate-Resistant Acid Phosphatase - genetics</subject><subject>Tartrate-Resistant Acid Phosphatase - metabolism</subject><subject>Vitamin D</subject><subject>Vitamin D - analogs &amp; derivatives</subject><subject>Vitamin D - metabolism</subject><issn>0960-0760</issn><issn>1879-1220</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kE1P3DAURS3UCgbaX4CELHXTTVK_eGIniy6qEV8SUjdlwcqynRfkkMSD7SDNv6-HgS66YHUXPu_66hByDqwEBuLHUA7RTKasGNQlQJnjiKygkW0BVcU-kRVrBSuYFOyEnMY4MMY4B3lMTioheCu4XJGHyxfX4WyR9j5QPSYM2FEfE3o76pj8I84YXaRupnE74uztLiG1y5iWgJH2wU90s9tW0gB9yq9Pfkl0cha_kM-9HiN-fcszcn91-WdzU9z9vr7d_LorLG9kKmqhubGGa2lq6HlepnVf55nrVlRNzW3frY1utZay1pXsWWssVKzRVncMOsHPyPdD7zb45wVjUpOLFsdRz-iXqKDJnWte101Gv_2HDn4Jc16noJWNEFkbyxQ_UDb4GAP2ahvcpMNOAVN782pQr-bV3rwCUDny1cVb92Im7P7dvKvOwM8DgFnGi8OgonV7850LaJPqvPvwg7_gsJWP</recordid><startdate>201611</startdate><enddate>201611</enddate><creator>Reinke, Daniel C.</creator><creator>Kogawa, Masakazu</creator><creator>Barratt, Kate R.</creator><creator>Morris, Howard A.</creator><creator>Anderson, Paul H.</creator><creator>Atkins, Gerald J.</creator><general>Elsevier Ltd</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2745-3750</orcidid></search><sort><creationdate>201611</creationdate><title>Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice</title><author>Reinke, Daniel C. ; Kogawa, Masakazu ; Barratt, Kate R. ; Morris, Howard A. ; Anderson, Paul H. ; Atkins, Gerald J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-56a3bcb3a7b51f3266aaf53174962853cfd4ba9aa775a27f09bc1208acad01d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>25-Hydroxyvitamin D</topic><topic>25-Hydroxyvitamin D3 1-alpha-Hydroxylase - deficiency</topic><topic>25-Hydroxyvitamin D3 1-alpha-Hydroxylase - genetics</topic><topic>Acid phosphatase (tartrate-resistant)</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Bcl-2 protein</topic><topic>bcl-2-Associated X Protein - genetics</topic><topic>bcl-2-Associated X Protein - metabolism</topic><topic>Bone resorption</topic><topic>Bone Resorption - genetics</topic><topic>Bone Resorption - metabolism</topic><topic>Bone Resorption - pathology</topic><topic>Calcitriol - metabolism</topic><topic>Cell cycle</topic><topic>Cell Differentiation</topic><topic>Clonal deletion</topic><topic>CYP27B1</topic><topic>Gene deletion</topic><topic>Gene Expression Regulation</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Osteoclast</topic><topic>Osteoclastogenesis</topic><topic>Osteoclasts</topic><topic>Osteoclasts - metabolism</topic><topic>Osteoclasts - pathology</topic><topic>Osteogenesis - genetics</topic><topic>Phosphatase</topic><topic>Primary Cell Culture</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Spleen - cytology</topic><topic>Spleen - metabolism</topic><topic>Splenocytes</topic><topic>Tartrate-Resistant Acid Phosphatase - genetics</topic><topic>Tartrate-Resistant Acid Phosphatase - metabolism</topic><topic>Vitamin D</topic><topic>Vitamin D - analogs &amp; derivatives</topic><topic>Vitamin D - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reinke, Daniel C.</creatorcontrib><creatorcontrib>Kogawa, Masakazu</creatorcontrib><creatorcontrib>Barratt, Kate R.</creatorcontrib><creatorcontrib>Morris, Howard A.</creatorcontrib><creatorcontrib>Anderson, Paul H.</creatorcontrib><creatorcontrib>Atkins, Gerald J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of steroid biochemistry and molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reinke, Daniel C.</au><au>Kogawa, Masakazu</au><au>Barratt, Kate R.</au><au>Morris, Howard A.</au><au>Anderson, Paul H.</au><au>Atkins, Gerald J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice</atitle><jtitle>The Journal of steroid biochemistry and molecular biology</jtitle><addtitle>J Steroid Biochem Mol Biol</addtitle><date>2016-11</date><risdate>2016</risdate><volume>164</volume><spage>353</spage><epage>360</epage><pages>353-360</pages><issn>0960-0760</issn><eissn>1879-1220</eissn><abstract>•Osteoclast differentiation in mice with global deletion of Cyp27b1 (Cyp27b1 KO) was studied.•Cyp27b1 KO splenocytes gave rise to fewer osteoclasts in response to recombinant RANKL/M-CSF.•Cyp27b1 KO derived osteoclasts had enhanced resorptive capacity. The association between increased serum 25-hydroxyvitamin D (25D) and reduced osteoclastic bone resorption is well known. Previously, we have demonstrated that mechanism by which this occurs, may include the conversion of 25D to 1,25-dihydroxyvitamin D (1,25D) by osteoclasts, catalysed by the CYP27B1 enzyme. Local 1,25D synthesis in osteoclasts was shown to regulate osteoclastogenesis and moderating resorptive activity. Thus, we hypothesised that osteoclasts differentiated from mice with global deletion of the Cyp27b1 gene (Cyp27b1 KO) would display enhanced resorptive capacity due to the lack of an ameliorating effect of 1,25D. Splenocytes isolated from Cyp27b1 KO mice or their wild-type (WT) littermates between 6 and 8 weeks of age were cultured under osteoclast-forming conditions for up to 14 days. Osteoclast formation was measured by staining for the osteoclast marker tartrate resistant acid phosphatase (TRAP). Bone resorption activity was measured by plating the cells on a bone-like substrate. In Cyp27b1 KO cultures, osteoclastogenesis was reduced, as indicated by fewer TRAP-positive multinucleated cells at all time points measured (p&lt;0.05) when compared to wild-type (WT) levels. However, Cyp27b1 KO osteoclasts demonstrated greater resorption on a per cell basis than their WT counterparts (p&lt;0.03). In addition, the ratio of expression of the pro-apoptotic gene Bax to the pro-survival gene Bcl-2 was decreased in Cyp27b1 KO cultures, implying that these smaller osteoclasts survive longer than WT osteoclasts. Our data indicate abnormal osteoclastogenesis due to the absence of CYP27B1 expression, consistent with the notion that endogenous metabolism of 25D optimises osteoclastogenesis and ameliorates the resulting activity of mature osteoclasts.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>26639637</pmid><doi>10.1016/j.jsbmb.2015.11.015</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-2745-3750</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0960-0760
ispartof The Journal of steroid biochemistry and molecular biology, 2016-11, Vol.164, p.353-360
issn 0960-0760
1879-1220
language eng
recordid cdi_proquest_miscellaneous_1826643558
source Elsevier
subjects 25-Hydroxyvitamin D
25-Hydroxyvitamin D3 1-alpha-Hydroxylase - deficiency
25-Hydroxyvitamin D3 1-alpha-Hydroxylase - genetics
Acid phosphatase (tartrate-resistant)
Animals
Apoptosis
Bcl-2 protein
bcl-2-Associated X Protein - genetics
bcl-2-Associated X Protein - metabolism
Bone resorption
Bone Resorption - genetics
Bone Resorption - metabolism
Bone Resorption - pathology
Calcitriol - metabolism
Cell cycle
Cell Differentiation
Clonal deletion
CYP27B1
Gene deletion
Gene Expression Regulation
Metabolism
Mice
Mice, Knockout
Osteoclast
Osteoclastogenesis
Osteoclasts
Osteoclasts - metabolism
Osteoclasts - pathology
Osteogenesis - genetics
Phosphatase
Primary Cell Culture
Proto-Oncogene Proteins c-bcl-2 - genetics
Proto-Oncogene Proteins c-bcl-2 - metabolism
Spleen - cytology
Spleen - metabolism
Splenocytes
Tartrate-Resistant Acid Phosphatase - genetics
Tartrate-Resistant Acid Phosphatase - metabolism
Vitamin D
Vitamin D - analogs & derivatives
Vitamin D - metabolism
title Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T21%3A47%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence%20for%20altered%20osteoclastogenesis%20in%20splenocyte%20cultures%20from%20Cyp27b1%20knockout%20mice&rft.jtitle=The%20Journal%20of%20steroid%20biochemistry%20and%20molecular%20biology&rft.au=Reinke,%20Daniel%20C.&rft.date=2016-11&rft.volume=164&rft.spage=353&rft.epage=360&rft.pages=353-360&rft.issn=0960-0760&rft.eissn=1879-1220&rft_id=info:doi/10.1016/j.jsbmb.2015.11.015&rft_dat=%3Cproquest_cross%3E1826643558%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c387t-56a3bcb3a7b51f3266aaf53174962853cfd4ba9aa775a27f09bc1208acad01d63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1978662200&rft_id=info:pmid/26639637&rfr_iscdi=true